Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Case report study of the first five COVID-19 patients treated with remdesivir in France.
Dubert M, Visseaux B, Isernia V, Bouadma L, Deconinck L, Patrier J, Wicky PH, Le Pluart D, Kramer L, Rioux C, Le Hingrat Q, Houhou-Fidouh N, Yazdanpanah Y, Ghosn J, Lescure FX. Dubert M, et al. Among authors: le hingrat q, le pluart d. Int J Infect Dis. 2020 Sep;98:290-293. doi: 10.1016/j.ijid.2020.06.093. Epub 2020 Jun 30. Int J Infect Dis. 2020. PMID: 32619764 Free PMC article.
Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients.
Storto A, Visseaux B, Bertine M, Le Hingrat Q, Collin G, Damond F, Khuong MA, Blum L, Tubiana R, Karmochkine M, Cazanave C, Matheron S, Descamps D, Charpentier C; ANRS HIV-2 CO5 Cohort. Storto A, et al. Among authors: le hingrat q. J Antimicrob Chemother. 2018 May 1;73(5):1173-1176. doi: 10.1093/jac/dkx530. J Antimicrob Chemother. 2018. PMID: 29415189
Presence of Human Papillomavirus (HPV) Apolipoprotein B Messenger RNA Editing, Catalytic Polypeptide-Like 3 (APOBEC)-Related Minority Variants in HPV-16 Genomes From Anal and Cervical Samples but Not in HPV-52 and HPV-58.
Mariaggi AA, Péré H, Perrier M, Visseaux B, Collin G, Veyer D, Le Hingrat Q, Ferré VM, Joly V, Couvelard A, Bucau M, Davitian C, Descamps D, Abramowitz L, Charpentier C. Mariaggi AA, et al. Among authors: le hingrat q. J Infect Dis. 2018 Aug 24;218(7):1027-1036. doi: 10.1093/infdis/jiy287. J Infect Dis. 2018. PMID: 29788374
HIV-2 Primary Infection in a French 69-Year-Old Bisexual Man.
Cazals N, Le Hingrat Q, Abraham B, Da Silva P, Guindre L, Goffart S, Damond F, Visseaux B, Charpentier C, Ranger-Rogez S, Descamps D. Cazals N, et al. Among authors: le hingrat q. Open Forum Infect Dis. 2018 Sep 11;5(10):ofy223. doi: 10.1093/ofid/ofy223. eCollection 2018 Oct. Open Forum Infect Dis. 2018. PMID: 30310823 Free PMC article.
A New Mechanism of Resistance of Human Immunodeficiency Virus Type 2 to Integrase Inhibitors: A 5-Amino-Acid Insertion in the Integrase C-Terminal Domain.
Le Hingrat Q, Collin G, Lê M, Peytavin G, Visseaux B, Bertine M, Tubiana R, Karmochkine M, Valin N, Collin F, Lemaignen A, Bernard L, Damond F, Matheron S, Descamps D, Charpentier C; French National Agency for Research on AIDS and Viral Hepatitis (ANRS) CO5 HIV-2 Cohort. Le Hingrat Q, et al. Among authors: le m. Clin Infect Dis. 2019 Aug 1;69(4):657-667. doi: 10.1093/cid/ciy940. Clin Infect Dis. 2019. PMID: 30383215
New insights are game-changers in HIV-2 disease management.
Le Hingrat Q, Charpentier C, Ghosn J, Thiébaut R, Peytavin G, Descamps D, Matheron S. Le Hingrat Q, et al. Lancet HIV. 2019 Apr;6(4):e214. doi: 10.1016/S2352-3018(19)30088-8. Lancet HIV. 2019. PMID: 30942186 No abstract available.
94 results